Effects of Esculentoside A on TNF-α and Sil-2R Levels in Peripheral Blood Mononuclear Cells from Psoriatic Patients

Junbao Du
2004-01-01
Abstract:Objective: To investigate the mechanisms of Esculentoside A (EsA) on the secretion levels of tumor necrosis factors (TNF-α) and soluble interleukin-2 receptors (sIL-2R) in peripheral blood mononuclear cells(PBMC) from patients with psoriasis vulgaris (PV). Methods: The heparinized peripheral blood was donated by 30 patients with psoriasis vulgaris and 20 healthy controls. PBMC were isolated by density centrifugation and stimulated with a mitogen (LPS or PHA) for 24 or 48 hours in the presence or absence of EsA. The secretion levels of TNF-α and sIL-2R from the supernatants of cultured PBMC were determined by enzyme-linked immunoabsorption assay (ELISA). Results: Under the different culture conditions, the secretion levels of TNF-α and sIL-2R increased in the patients compared to the controls. TNF-α level decreased significuntly in psoriatic patients when the concentration of EsA was over 1.0 μg/mL (P 0.05). There was a EsA dose-dependent inhibition in the secretion of TNF-α under the series of concentrations(1.0~10.0 μg/mL ). There was statistically significant differenceof TNF-α secretion between psoriatic and control subjects(P 0.05). sIL-2R decreased slightly and showed no statistics difference between the tow groups(P 0.05). Conclusion: EsA suppresses the secretion release of TNF-α in PBMC in vitro. The inhibitory effects of ESA could contribute to its anti-inflammatory activity, which plays a beneficial role in the treatment of psoriasis.
What problem does this paper attempt to address?